RN7SL539P

Across TCGA pan-cancer cohorts, RN7SL539P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RN7SL539P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RN7SL539P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL539P expression acts as an unfavorable survival marker.

SKCM, OV, and LUAD are the cancer types where RN7SL539P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.249	0.783	.008	63	view →
OV	OS	Tertile	All	0.253	0.690	.010	54	view →
LUAD	OS	Tertile	All	0.161	0.788	.001	36	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RN7SL539P–SKCM (OS)

Open the SKCM breakdown →